BioMarin Pharmaceutical's total assets for Q4 2025 were $7.59B, a decrease of -0.27% from the previous quarter. DE:BM8 total liabilities were $1.51B for the fiscal quarter, a -3.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.